Analysing forecasted sales of analgesic medicines in Australia from 2024 to 2028, we observe a consistent upward trend. The forecasted sales are expected to reach approximately $477.9 million in 2024, gradually increasing to $529.6 million by 2028. These figures represent forecasted data, with the 2023 actual sales serving as the baseline.
The year-on-year growth rates are as follows: 2024-2025 exhibits a 3.7% increase, 2025-2026 shows a 2.8% increase, 2026-2027 has a 2.2% increase, and 2027-2028 presents a 1.7% increase. Over the last two years, the compound annual growth rate (CAGR) stands at approximately 2.8%, reflecting robust demand in the analgesic market.
Future trends to watch for include the influence of emerging healthcare technologies, population aging, and increasing awareness about pain management. These factors are likely to spur further growth in the analgesic medicine market in Australia.
